Dalid, Moises P.

HRN: 06-35-24  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/27/2023
CEFTRIAXONE 1G (VIAL)
01/27/2023
02/03/2023
IV
2 Grams
Q24H
CAP-MR
Waiting Final Action 
01/27/2023
AZITHROMYCIN 500MG TABLET (TAB)
01/27/2023
02/01/2023
PO
1 Tab
OD
CAP-MR
Waiting Final Action 
02/02/2023
CEFTAZIDIME 1GM (VIAL)
02/02/2023
02/09/2023
IV
1g
Q8
Progressing Pneumonia
Waiting Final Action 
02/02/2023
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
02/02/2023
02/09/2023
IV
750mg
OD Every Other Day
Progressing Pneumonia
Waiting Final Action 
02/02/2023
LEVOFLOXACIN 500MG (TAB)
02/02/2023
02/08/2023
PO
1 1/2 Tab
OD Every Other Day
CAP-MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: